📰 Interim Head News
Page 26 - Interim Head News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interim Head. Real-time updates on events, politics, business and more.
October 21, 2022
At least three nonprofits citing a requirement to post their nondiscrimination policies will not take part in this year’s ExtraGive.
October 21, 2022
Public health officials are urging people in eligible groups to take up the offer of a Covid-19 booster vaccine. It comes as community transmission, hospitalisations and deaths from Covid-19 have increased in recent weeks. The Covid vaccine is the most effective way to prevent severe illness from Covid-19. Protection from previous Covid-19 vaccinations does reduce […]
October 19, 2022
The Food and Drug Administration (FDA) has extended the review periods for 2 investigational products: sparsentan and tofersen.
October 17, 2022
The new Prescription Drug User Fee Act (PDUFA) action date set by the FDA is April 25, 2023 CAMBRIDGE, Mass., Oct. 17, 2022Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration
October 11, 2022
There are approximately 350,00 stay-at-home parents in Ireland.And a staggering 94 per cent of these unsung heroes are women.The slog they do for thei
October 11, 2022
The Maine Charter School Commission narrowly rejected Harpswell Coastal Academy's charter renewal application Tuesday afternoon, ending the school's months-long fight for survival.
October 6, 2022
The Purdue University student accused of killing his roommate told reporters "I love my family" when entering jail on Wednesday afternoon.
October 6, 2022
Ji Min Sha, 22, charged with the murder of his University dorm roommate Varun Manish Chheda, 20, has sent his love to his family before entering jail.
October 6, 2022
CSL Seqirus will manufacture and clinically assess a cell-based, adjuvanted pre-pandemic influenza vaccine candidate to support the U.S. governmen...
October 5, 2022
Data published in Molecular Therapy – Methods and Clinical Development confirm the potential preclinical benefit of the sa-mRNA technology platfor...